MicroRNA-210 Regulates Mitochondrial Free Radical Response to Hypoxia and Krebs Cycle in Cancer Cells by Targeting Iron Sulfur Cluster Protein ISCU
Open accessThe DOI matches its Crossref record; 45 of the 46 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Hypoxia in cancers results in the upregulation of hypoxia inducible factor 1 (HIF-1) and a microRNA, hsa-miR-210 (miR-210) which is associated with a poor prognosis. METHODS AND FINDINGS: In human cancer cell lines and tumours, we found that miR-210 targets the mitochondrial iron sulfur scaffold protein ISCU, required for assembly of iron-sulfur clusters, cofactors for key enzymes involved in the Krebs cycle, electron transport, and iron metabolism. Down regulation of ISCU was the major cause of induction of reactive oxygen species (ROS) in hypoxia. ISCU suppression reduced mitochondrial complex 1 activity and aconitase activity, caused a shift to glycolysis in normoxia and enhanced cell survival. Cancers with low ISCU had a worse prognosis. CONCLUSIONS: Induction of these major hallmarks of cancer show that a single microRNA, miR-210, mediates a new mechanism of adaptation to hypoxia, by regulating mitochondrial function via iron-sulfur cluster metabolism and free radical generation.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures





Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Similarly, in other studies, miR210-mediated suppression of ETC and TCA enzymes were found to correlate with enhanced anaerobic glycolysis and increases in lactate production (81, 129).”
From Redox regulation of mitochondrial function (2012) · cites this paper as [129]
In the citing paper
“Subsequent studies by other investigators confirm the role of miR210 in suppressing ISCU1/2 and as well as other factors (cytochrome c oxidase assembly protein) essential for ETC assembly (81, 129).”
From Redox regulation of mitochondrial function (2012) · cites this paper as [129]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Mitochondrial Autophagy Is an HIF-1-dependent Adaptive Metabolic Response to Hypoxia
Zhang, H., Bosch-Marce, M., Shimoda, L. A., Tan, Y. S., Baek, J. H., Wesley, J. B., Gonzalez, F. J., & Semenza, G. L. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m800102200 · Cited by 1,601 · cited 2×
“induced by the BH3 domain protein BNIP3, [8], and cytochrome C oxidase subunits may switch to more efficient ones [9].”
BackgroundRetractedMicroRNAs: Target Recognition and Regulatory Functions
Bartel, D. P. (2009) · Cell · doi:10.1016/j.cell.2009.01.002 · Cited by 20,068 · cited 1×
“Recently microRNAs (miRs), which are small (,22 nt) noncoding RNAs that regulate post-transcriptional gene expression by blocking translation of target mRNAs or by accelerating their degradation [10,11], have been reported to be induced by hypoxia.”
In silico prediction of protein-protein interactions in human macrophages
Souiai, O., Guerfali, F., Ben Miled, S., Brun, C., & Benkahla, A. (2014) · BMC Research Notes · doi:10.1186/1756-0500-7-157 · Cited by 10,803
Significance analysis of microarrays applied to the ionizing radiation response
Tusher, V. G., Tibshirani, R., & Chu, G. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.091062498 · Cited by 10,568
How mitochondria produce reactive oxygen species
Murphy, M. P. (2009) · Biochemical Journal · doi:10.1042/bj20081386 · Cited by 8,207 · cited 10×
“In particular, complex III is a major contributor to ROS in hypoxia [32] and complex I and II contribute about 30% of the ROS [33].”
BackgroundInfluential(2008) · doi:10.1038/nrg2290 · Cited by 5,199
Hypoxia — a key regulatory factor in tumour growth
Harris, A. L. (2002) · Nature Reviews Cancer · doi:10.1038/nrc704 · Cited by 5,177 · cited 1×
“Hypoxia is a major physiological difference between tumours and normal tissue, mainly generated by tumour growth with inadequate blood supply and consumption of oxygen by tumour cells [reviewed in [1]].”
BackgroundSelf-citationGene-expression profiles to predict distant metastasis of lymph-node-negative primary breast cancer
Wang, Y., Klijn, J. G., Zhang, Y., Sieuwerts, A. M., Look, M. P., Yang, F., Talantov, D., Timmermans, M., Meijer-van Gelder, M. E., Yu, J., et al. (2005) · The Lancet · doi:10.1016/s0140-6736(05)17947-1 · Cited by 2,846
Lawrie, C. H., Gal, S., Dunlop, H. M., Pushkaran, B., Liggins, A. P., Pulford, K., Banham, A. H., Pezzella, F., Boultwood, J., Wainscoat, J. S., et al. (2008) · British Journal of Haematology · doi:10.1111/j.1365-2141.2008.07077.x · Cited by 1,735 · cited 1×
“We have previously shown miR-210 can be detected at an elevated level in serum of cancer patients [38] so it will be of interest if they reflect the metabolic state of their primary cancer and hence could be used in future therapy selection.”
BackgroundSelf-citationMitochondrial complex III is required for hypoxia-induced ROS production and cellular oxygen sensing
Guzy, R. D., Hoyos, B., Robin, E., Chen, H., Liu, L., Mansfield, K. D., Simon, M. C., Hammerling, U., & Schumacker, P. T. (2005) · Cell Metabolism · doi:10.1016/j.cmet.2005.05.001 · Cited by 1,545 · cited 13×
“Found at: doi:10.1371/journal.pone.0010345.s005 (0.97 MB TIF) Figure S5 Hypoxia regulates ISCU via HIF1a induction of miR-210. miR-210 represses ISCU 39-UTR and reduces ISCU protein.”
BackgroundInfluential
Cited by
Items 101–200 of 326
Decreased global methylation in patients with bipolar disorder who respond to lithium
Huzayyin, A. A., Andreazza, A. C., Turecki, G., Cruceanu, C., Rouleau, G. A., Alda, M., & Young, L. T. (2014) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145713001569 · Cited by 80
Frataxin deficiency promotes endothelial senescence in pulmonary hypertension
Culley, M. K., Zhao, J., Tai, Y., Tang, Y., Perk, D., Negi, V., Yu, Q., Woodcock, C.-S. C., Handen, A. L., Speyer, G., et al. (2021) · Journal of Clinical Investigation · doi:10.1172/jci136459 · Cited by 87
“These results are supported by prior findings in other hypoxic cell types (41, 77).”
ResultAnti-tumor Activity of miniPEG-γ-Modified PNAs to Inhibit MicroRNA-210 for Cancer Therapy
Gupta, A., Quijano, E., Liu, Y., Bahal, R., Scanlon, S. E., Song, E., Hsieh, W.-C., Braddock, D. T., Ly, D. H., Saltzman, W. M., et al. (2017) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2017.09.001 · Cited by 83
“A predicted effect of inhibition of miR-210 would be the rescue in expression of ISCU protein, a known downstream target of miR210 that has been shown to be suppressed upon increased expression of miR-210 under hypoxic conditions.(15,39) To confirm miR-210 inhibition at a functional level in the tumors treated with gP…”
ResultSelf-citationCiccarone, F., Leo, L. D., Lazzarino, G., Maulucci, G., Giacinto, F. D., Tavazzi, B., & Ciriolo, M. R. (2019) · British Journal of Cancer · doi:10.1038/s41416-019-0641-0 · Cited by 88
miR-210 suppresses BNIP3 to protect against the apoptosis of neural progenitor cells
Wang, F., Xiong, L., Huang, X. H., Zhao, T., Wu, L., Liu, Z., Ding, X., Liu, S., Wu, Y., Zhao, Y., et al. (2013) · Stem Cell Research · doi:10.1016/j.scr.2013.04.005 · Cited by 83
Hypoxia- and MicroRNA-Induced Metabolic Reprogramming of Tumor-Initiating Cells
Ullmann, P., Nurmik, M., Begaj, R., Haan, S., & Letellier, E. (2019) · Cells · doi:10.3390/cells8060528 · Cited by 77
“These findings were confirmed by Favaro and colleagues, who additionally reported that the miR-210-induced inhibition of ISCU leads to reduced aconitase and mitochondrial complex I activity, thereby triggering a metabolic shift towards enhanced glycolysis and increased cancer cell proliferation [105].”
BackgroundMicroRNAs as regulators of mitochondrial function: Role in cancer suppression
Tomasetti, M., Neužil, J., & Dong, L. (2013) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2013.09.002 · Cited by 80
Knockdown of miR-210 decreases hypoxic glioma stem cells stemness and radioresistance
Yang, W., Wei, J., Guo, T., Shen, Y., & Liu, F. (2014) · Experimental Cell Research · doi:10.1016/j.yexcr.2014.05.022 · Cited by 77
Giannetto, A., Maisano, M. S., Cappello, T., Oliva, S., Parrino, V., Natalotto, A., Marco, G. D., Barberi, C., Romeo, O., Mauceri, A., et al. (2015) · Marine Biotechnology · doi:10.1007/s10126-015-9655-7 · Cited by 82
Crosstalk of MicroRNAs and Oxidative Stress in the Pathogenesis of Cancer
Lu, C., Zhou, D., Wang, Q., Liu, W., Yu, F., Wu, F., & Chen, C. (2020) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2020/2415324 · Cited by 85
“miR-210 Mitochondrial pathway ISCU downregulation; leading to upregulation of mitochondrial complex I activity and upregulation of mitochondrial ROS production Cancer [30, 112]”
BackgroundHIF-1α Metabolic Pathways in Human Cancer
Elzakra, N., & Kim, Y. (2021) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-51652-9_17 · Cited by 77
miRNAs as potential therapeutic targets for age-related macular degeneration
Wang, S., Koster, K. M., He, Y., & Zhou, Q. (2012) · Future Medicinal Chemistry · doi:10.4155/fmc.11.176 · Cited by 67
Effects of formaldehyde on mitochondrial dysfunction and apoptosis in SK-N-SH neuroblastoma cells
Zerin, T., Kim, J., Gil, H., Song, H., & Hong, S. (2015) · Cell Biology and Toxicology · doi:10.1007/s10565-015-9309-6 · Cited by 69
MicroRNAs: exploring a new dimension in the pathogenesis of kidney cancer
White, N. M. A., & Yousef, G. M. (2010) · BMC Medicine · doi:10.1186/1741-7015-8-65 · Cited by 64
“miR-210 increases under hypoxic conditions and can target the iron-sulphur cluster protein (ISCU) which is involved in the mitochondrial electron transport chain, suggesting a potential mechanism for regulating anaerobic respiration in tumours [1,16,17].”
BackgroundMicroRNA modulation of lipid metabolism and oxidative stress in cardiometabolic diseases
Aranda, J. F., Madrigal-Matute, J., Rotllan, N., & Fernández-Hernando, C. (2013) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2013.07.014 · Cited by 66
“MiR-210 has recently been described to regulate the activity of prototypical iron–sulfur scaffold protein (ISCU), controlling mitochondrial metabolism and free radical response in response to hypoxia [87,88].”
Epigenetic Regulation in Chromium-, Nickel- and Cadmium-Induced Carcinogenesis
Zhao, L., Islam, R., Wang, Y., Zhang, X., & Liu, L.-Z. (2022) · Cancers · doi:10.3390/cancers14235768 · Cited by 79
“Notably, this HIF1α/miR-210/ISCU1/2/energy metabolism regulatory axis has been reported in different cell types [154,155], including BEAS-2B cells [156].”
BackgroundProlyl hydroxylase domain enzymes: important regulators of cancer metabolism
Pollard, P. J., Yang, M., Su, H., Soga, T., & Kranc, K. R. (2014) · Hypoxia · doi:10.2147/hp.s47968 · Cited by 87
“33 Further, HIF1 regulates the expression of micro-RNA mir-210, causing downregulation of the Complex I subunit NDUFA4 (NADH dehydrogenase [ubiquinone] 1 alpha subcomplex), Complex II subunit SDHD (subunit D of succinate dehydrogenase [SDH] complex), the iron-sulfur cluster scaffold proteins 1/2 and the cytochrome c o…”
BackgroundJi, J., Qin, Y., Ren, J., Lu, C., Wang, R., Dai, X., Zhou, R., Huang, Z., Xu, M., Chen, M., et al. (2015) · Scientific Reports · doi:10.1038/srep16262 · Cited by 67
Myatt, L., Muralimanoharan, S., & Maloyan, A. (2014) · Advances in experimental medicine and biology · doi:10.1007/978-1-4939-1031-1_12 · Cited by 71
“Mir-210 regulates the expression of ISCU, a key factor in the assembly of Fe-S cluster subunits of complexes I, II and III in the mitochondria of cancer cells [ 100 ].”
BackgroundJung, Y.-D., Park, S.-K., Kang, D., Hwang, S., Kang, M.-H., Hong, S., Moon, J.-H., Shin, J.-S., Jin, D., You, D., et al. (2020) · Redox Biology · doi:10.1016/j.redox.2020.101716 · Cited by 68
Ullmann, P., Qureshi-Baig, K., Rodriguez, F., Ginolhac, A., Nonnenmacher, Y., Ternes, D., Weiler, J., Gäbler, K., Bahlawane, C., Hiller, K., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.11772 · Cited by 64
“As miR-210-induced repression of ISCU has been linked to altered metabolic activity in other cancer types [41,44], we hypothesized that this signaling axis might also be involved in the regulation of colon TIC activity.”
BackgroundMitochondria and Hypoxia: Metabolic Crosstalk in Cell-Fate Decisions
Bargiela, D., Burr, S. P., & Chinnery, P. F. (2018) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2018.02.002 · Cited by 60
Zhao, D.-S., Chen, Y., Jiang, H., Lu, J., Zhang, G., Geng, J., Zhang, Q. H., Shen, J.-H., Xin Min, Z. H. O. U., Zhu, W., et al. (2013) · Cardiovascular Pathology · doi:10.1016/j.carpath.2013.04.001 · Cited by 59
Bao, B., Azmi, A. S., Li, Y., Ahmad, A., Ali, S. S., Banerjee, S., Kong, D., & Sarkar, F. H. (2013) · Current Stem Cell Research & Therapy · doi:10.2174/1574888x113089990053 · Cited by 60
Role of cardiac progenitor cell‐derived exosome‐mediated microRNA‐210 in cardiovascular disease
Wang, L., Jia, Q., Chen, X., Xie, Y., Yang, Y., Zhang, A., Liu, R., Yuan, Z., & Zhang, J. (2019) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.14562 · Cited by 61
Hypoxia signaling: Challenges and opportunities for cancer therapy
Ivan, M., Fishel, M. L., Tudoran, O. M., Pollok, K. E., Wu, X., & Smith, P. J. (2021) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2021.10.002 · Cited by 62
Self-citationLi, L., Huang, K., You, Y., Fu, X., Hu, L., Song, L., & Meng, Y. (2014) · International Journal of Oncology · doi:10.3892/ijo.2014.2368 · Cited by 59
“The anti-apoptotic effect of miR-210 was achieved by inhibiting the target genes, such as EFNA3 (61), ISCU (62), E2F3 (63) and FGFRL1 (57).”
BackgroundMicroRNAs in pancreatic cancer metabolism
Singh, P. K., Brand, R. E., & Mehla, K. (2012) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2012.63 · Cited by 62
Frataxin participates to the hypoxia-induced response in tumors
Guccini, I., Serio, D., Condò, I., Rufini, A., Tomassini, B., Mangiola, A., Maira, G., Anile, C., Fina, D., Pallone, F., et al. (2011) · Cell Death and Disease · doi:10.1038/cddis.2011.5 · Cited by 64
Benzo[a]pyrene-Induced Changes in MicroRNA–mRNA Networks
Lizárraga, D., Gaj, S., Brauers, K. J. J., Timmermans, L., Kleinjans, J. C. S., & van Delft, J. H. M. (2012) · Chemical Research in Toxicology · doi:10.1021/tx2003799 · Cited by 57
Deng, Z., Du, W. W., Fang, L., Shan, S. W., Qian, J., Lin, J., Qian, W., Ma, J., Rutnam, Z. J., & Yang, B. B. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.418830 · Cited by 54
“It is highly expressed in the brain and plays a critical role in the development of the neural system (32, 52).”
BackgroundHe, M., Lu, Y., Xu, S., Mao, L., Zhang, L., Duan, W., Liu, C., Pi, H., Zhang, Y., Zhong, M., et al. (2014) · Cell Death and Disease · doi:10.1038/cddis.2014.60 · Cited by 56
MicroRNA-210 induces apoptosis in colorectal cancer via induction of reactive oxygen
Tagscherer, K. E., Fassl, A., Sinkovic, T., Richter, J., Schecher, S., Macher‐Goeppinger, S., & Roth, W. (2016) · Cancer Cell International · doi:10.1186/s12935-016-0321-6 · Cited by 59
“Furthermore, it has been shown that an elevated expression of miR-210 reduces oxygen consumption and upregulates glycolysis in various tumor entities [39, 40, 42, 58].”
BackgroundImpact of MicroRNAs in the Cellular Response to Hypoxia
Bertero, T., Rezzonico, R., Pottier, N., & Mari, B. P. (2017) · International review of cytology · doi:10.1016/bs.ircmb.2017.03.006 · Cited by 62
Abdelmaksoud, N. M., Abulsoud, A. I., Abdelghany, T. M., Elshaer, S. S., Rizk, S. M., & Senousy, M. A. (2023) · Pathology - Research and Practice · doi:10.1016/j.prp.2023.154509 · Cited by 58
Christie, D. A., Mitsopoulos, P., Blagih, J., Dunn, S. D., St‐Pierre, J., Jones, R. G., Hatch, G. M., & Madrenas, J. (2012) · The Journal of Immunology · doi:10.4049/jimmunol.1103829 · Cited by 57
Hypoxia-Induced miR-210 Modulates Tissue Response to Acute Peripheral Ischemia
Zaccagnini, G., Maimone, B., Stefano, V. D., Fasanaro, P., Greco, S., Perfetti, A., Capogrossi, M. C., Gaetano, C., & Martelli, F. (2014) · Antioxidants and Redox Signaling · doi:10.1089/ars.2013.5206 · Cited by 56
“…and cancer cells show that miR-210 is a crucial regulator of mitochondrial metabolism: by downregulating the expression of ISCU1/2, NDU-FA2, COX10, and SDH, miR-210 disrupts the mitochondrial electron transport activity, repressing mitochondrial oxidative phosphorylation (6, 8, 15, 17, 46).”
InfluentialCortez, M. A., Ivan, C., Zhou, P., Wu, X., Ivan, M., & Calin, G. A. (2010) · Advances in cancer research · doi:10.1016/b978-0-12-380888-2.00004-2 · Cited by 59
“What are the biological and biochemical implications of upregulation of miR-210 expression induced by hypoxia? Although relevant data are just now emerging, several groups have reported that miR-210 links hypoxia with reactive oxygen species generation, decreased Krebs cycle activity, and electron transport in mitocho…”
BackgroundSelf-citationNew emerging roles of microRNAs in breast cancer
Mandujano-Tinoco, E. A., García-Venzor, A., Meléndez-Zajgla, J., & Maldonado, V. (2018) · Breast Cancer Research and Treatment · doi:10.1007/s10549-018-4850-7 · Cited by 62
Onganer, P. U., MacLatchy, A., Rayan, M., Kraev, I., Thompson, P. R., Inal, J. M., & Lange, S. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21041495 · Cited by 57
“miR210 has been identified as a regulator of the hypoxia pathway [84,85] and belongs to a group of hypoxia-mediated microRNAs, which are upregulated in glioma compared to normal brain tissue [86] and upregulated in patient-derived glioblastoma spheroids upon hypoxia exposure [87].”
BackgroundHypoxia and Metabolism in Cancer
Bensaad, K., & Harris, A. L. (2013) · Advances in experimental medicine and biology · doi:10.1007/978-1-4614-5915-6_1 · Cited by 53
Self-citationMerlo, A., Fernández, S. B. D. Q., Secades, P., Zambrano, I., Balbín, M., Astudillo, A., Scola, B., Arístegui, M., Suarez, C. M., & Chiara, M. (2012) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2012-2410 · Cited by 55
MicroRNAs and the Warburg Effect: New Players in an Old Arena
Gao, P., Sun, L., He, X., Cao, Y., & Zhang, H. (2012) · Current Gene Therapy · doi:10.2174/156652312802083620 · Cited by 55
A Complex Genome-MicroRNA Interplay in Human Mitochondria
Shinde, S., & Bhadra, U. (2015) · BioMed Research International · doi:10.1155/2015/206382 · Cited by 51
Xu, J., Huang, Z., Li, L., Fu, M., Gao, Y., Shen, Y., Zou, Y., Sun, A., Qian, J., & Ge, J. (2014) · Science China Life Sciences · doi:10.1007/s11427-014-4725-z · Cited by 50
Microtargeting cancer metabolism: opening new therapeutic windows based on lipid metabolism
de Cedrón, M. G., & de Molina, A. R. (2016) · Journal of Lipid Research · doi:10.1194/jlr.r061812 · Cited by 53
Redox Regulation and Noncoding RNAs
Leisegang, M. S., Schröder, K., & Brandes, R. P. (2017) · Antioxidants and Redox Signaling · doi:10.1089/ars.2017.7276 · Cited by 51
“Collectively, miRNA-210 appears to potentiate ROS generation (except in rat cardiomyocytes) (37, 38, 106, 137).”
Iron–Sulfur Cluster Biogenesis as a Critical Target in Cancer
Petronek, M. S., Spitz, D. R., & Allen, B. G. (2021) · Antioxidants · doi:10.3390/antiox10091458 · Cited by 54
“Due to its well-known role in Friedreich’s Ataxia (FA) [97], FXN has been a point of interest in cancer research.”
BackgroundObstructive Sleep Apnea–induced Endothelial Dysfunction Is Mediated by miR-210
Shang, F., Wang, S., Gongol, B., Han, S. Y., Cho, Y., Schiavon, C. R., Chen, L., Xing, Y., Zhao, Y., Ning, M., et al. (2023) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.202202-0394oc · Cited by 52
Sun, W., Zhao, L., Song, X., Zhang, J., Xing, Y., Liu, N., Yan, Y., Li, Z., Lu, Y., Wu, J., et al. (2017) · Cellular Physiology and Biochemistry · doi:10.1159/000480417 · Cited by 50
Sen, C. K. (2011) · Physiological Genomics · doi:10.1152/physiolgenomics.00037.2011 · Cited by 45
Sun, J., Zhao, L., Wu, H., Lian, W., Cui, C., Du, Z., Luo, W., Li, M., & Yang, S. Y. (2018) · Functional & Integrative Genomics · doi:10.1007/s10142-018-0643-7 · Cited by 53
miR-210 hypoxamiR in Angiogenesis and Diabetes
Zaccagnini, G., Greco, S., Voellenkle, C., Gaetano, C., & Martelli, F. (2022) · Antioxidants and Redox Signaling · doi:10.1089/ars.2021.0200 · Cited by 50
“HIF-1 can inhibit both mitochondrial respiration and mitochondrial electron transport chain activity, leading to the metabolic shift from aerobic oxidative phosphorylation to anaerobic glycolysis, with a mechanism that is also mediated by the transcriptional activation of miR-210 (22, 46).”
InfluentialInsights into the Regulatory Role of Non-coding RNAs in Cancer Metabolism
Beltrán‐Anaya, F. O., Cedro‐Tanda, A., Hidalgo‐Miranda, A., & Romero-Cordoba, S. L. (2016) · Frontiers in Physiology · doi:10.3389/fphys.2016.00342 · Cited by 50
“Particularly, miR210 targets ISCU1 and ISCU2, suppressing mitochondrial function and disrupting iron homeostasis in colon, breast, and esophageal cancer (Chen et al., 2010; Favaro et al., 2010).”
BackgroundVoloboueva, L. A., Sun, X., Xu, L., Ouyang, Y., & Giffard, R. G. (2017) · Journal of Neuroscience · doi:10.1523/jneurosci.1777-16.2017 · Cited by 46
“Because microRNAs coordinately regulate multiple targets, they are attractive candidates for development of new therapies. miR-210 downregulates mitochondrial function and mediates the metabolic switch to glycolysis (Chen et al., 2010; Favaro et al., 2010; White et al., 2015).”
BackgroundMethodInfluentialRegression of A549 lung cancer tumors by anti-miR-150 vector
Lv, C. (2011) · Oncology Reports · doi:10.3892/or.2011.1466 · Cited by 44
“In addition, miRNAs have been shown to regulate the expression of hypoxia-related genes and of the vascular endothelial growth factor (16,17).”
Bae, S., LEE, E.-J., Lee, J. H., Park, I., Lee, S., Hahn, H. J., Ahn, K. J., An, S., An, I., & Cha, H. J. (2013) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2013.1561 · Cited by 47
Induction, modulation and potential targets of miR-210 in pancreatic cancer cells
Chen, W., Liu, W., Zhao, Y.-P., Zhou, L., Zhang, T., Chen, G., & Shu, H. (2012) · Hepatobiliary & pancreatic diseases international · doi:10.1016/s1499-3872(12)60168-4 · Cited by 42
Saumet, A., Vetter, G., Bouttier, M., Antoine, E., Roubert, C., Orsetti, B., Theillet, C. G., & Lecellier, C. (2012) · Molecular BioSystems · doi:10.1039/c2mb25298h · Cited by 40
Tissue-specific changes in fatty acid oxidation in hypoxic heart and skeletal muscle
Morash, A. J., Kotwica, A. O., & Murray, A. J. (2013) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00510.2012 · Cited by 43
“First, iron-sulfur cluster assembly proteins may be subject to ROS-mediated disruption thereby reducing total aconitase protein as suggested by work in various cell lines (7, 11).”
BackgroundRenal cell carcinoma: translational aspects of metabolism and therapeutic consequences
Yang, O. C. Y., Maxwell, P. H., & Pollard, P. J. (2013) · Kidney International · doi:10.1038/ki.2013.245 · Cited by 41
Qiu, J., Zhou, X., Zhou, X., Cheng, R., Liu, H., & Li, Y. (2013) · Molecular Medicine Reports · doi:10.3892/mmr.2013.1431 · Cited by 39
miR-210: a therapeutic target in cancer
Hong, L., Han, Y., Zhang, H., Zhao, Q., & Qiao, Y. (2012) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.2012.732066 · Cited by 41
“ISCU (iron-sulfur cluster scaffold homolog) and COX10 (cytochrome c oxidase assembly protein), two important factors of the mitochondria electron transport chain and the tricarboxylic acid cycle, have been identified as potential targets of miR-210 [37,57].”
BackgroundSala, V., Bergerone, S., Gatti, S., Gallo, S., Ponzetto, A., Ponzetto, C., & Crepaldi, T. (2013) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-013-1504-0 · Cited by 40
“Furthermore, miR-210 regulates mitochondrial metabolism by targeting crucial proteins of the electron transport chain, at least in cancer cells [66–68].”
BackgroundWang, W., Liu, Y., Niu, J., & Lin, W. (2019) · The Analyst · doi:10.1039/c9an01573f · Cited by 37
Expression analysis and function of mitochondrial genome-encoded microRNAs
Kuthethur, R., Shukla, V., Mallya, S. P., Adiga, D., Kabekkodu, S. P., Ramachandra, L., Saxena, P. P., Satyamoorthy, K., & Chakrabarty, S. (2022) · Journal of Cell Science · doi:10.1242/jcs.258937 · Cited by 39
The Role of Hypoxia Regulated microRNAs in Cancer
McCormick, R., Buffa, F. M., Ragoussis, J., & Harris, A. L. (2010) · Current topics in microbiology and immunology · doi:10.1007/82_2010_76 · Cited by 39
“…method has been recently applied to a large breast cancer dataset (N ¼ 219) and has identified the iron–sulphur cluster scaffold homolog (ISCU, alias NIFU) as a miR-210 target (Favaro et al. 2010), which was confirmed by experimental validation both in cancer and normal tissues (Chan et al. 2009).”
MethodSelf-citationProtection of Human Umbilical Vein Endothelial Cells against Oxidative Stress by MicroRNA‐210
Li, T., Song, X., Zhang, J., Zhao, L., Shi, Y., Li, Z., Liu, J., Liu, N., Yan, Y., Xiao, Y., et al. (2017) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2017/3565613 · Cited by 36
“the reducedROS generation could be related to the regulation of the c-Met pathway [11] and the expression of iron-sulfur cluster scaffold homolog [23].”
BackgroundInfluentialMicroRNA regulation of cancer metabolism: role in tumour suppression
Tomasetti, M., Santarelli, L., Neužil, J., & Dong, L. (2014) · Mitochondrion · doi:10.1016/j.mito.2014.06.004 · Cited by 38
Ferecatu, I., Canal, F., Fabbri, L., Mazure, N. M., Bouton, C., & Golinelli‐Cohen, M. (2018) · PLoS ONE · doi:10.1371/journal.pone.0194782 · Cited by 38
Hu, X., & Zhang, L. (2021) · Drug Discovery Today · doi:10.1016/j.drudis.2021.07.011 · Cited by 40
“Seed-Milarity” Confers to hsa-miR-210 and hsa-miR-147b Similar Functional Activity
Bertero, T., Grosso, S., Robbe-Sermesant, K., Lebrigand, K., Hénaoui, I. S., Puisségur, M.-P., Fourré, S., Zaragosi, L., Mazure, N. M., Ponzio, G., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0044919 · Cited by 36
“This effect could be likely mediated by the targeting of several mitochondrial components by these 2 miRNAs, such as ISCU, NDUFA4 or SDHD, inducing mitochondrial dysfunctions associated with induction of reactive oxygen species, decrease of mitochondrial membrane potential and caspase-3 activation [26,43,44].”
BackgroundDubey, S., Shrinet, J., & Sunil, S. (2019) · PLoS neglected tropical diseases · doi:10.1371/journal.pntd.0007429 · Cited by 34
miRNA in tumour metabolism and why could it be the preferred pathway for energy reprograming
Alamoudi, A. A., Alnoury, A., & Gad, H. (2017) · Briefings in Functional Genomics · doi:10.1093/bfgp/elx023 · Cited by 37
Targeting Cellular Metabolism Modulates Head and Neck Oncogenesis
Hsieh, Y.-T., Chen, Y., Lin, S., Chang, K., & Li, W. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20163960 · Cited by 34
Sánchez-Jiménez, C., Carrascoso, I., Barrero, J. J., & Izquierdo, J. M. (2013) · BMC Molecular Biology · doi:10.1186/1471-2199-14-4 · Cited by 38
“Further, this miRNA modulates the mitochondrial functioning and metabolism [49,50], represses FGFRL1 and E2F3 expression, which inhibits cell apoptosis in hypoxia response [51,52], predicts poor survival in patients with breast cancer [53] and activates notch signalling pathway in”
BackgroundViollet, C., Davis, D. A., Tekeste, S. S., Reczko, M., Ziegelbauer, J. M., Pezzella, F., Ragoussis, J., & Yarchoan, R. (2017) · PLoS Pathogens · doi:10.1371/journal.ppat.1006143 · Cited by 33
“Finally, ISCU was significantly up-regulated as compared to hypoxic anti-ctrl when miR-210 inhibitors were transfected, as had been described in other cell systems [62].”
InfluentialSelf-citationBiagiotti, S., Canonico, B., Tiboni, M., Abbas, F., Perla, E., Montanari, M., Battistelli, M., Papa, S., Casettari, L., Rossi, L., et al. (2024) · Scientific Reports · doi:10.1038/s41598-024-65623-y · Cited by 38
Sáenz‐de‐Santa‐María, I., Bernardo‐Castiñeira, C., Secades, P., Fernández, S. B. D. Q., Rodrigo, J. P., Astudillo, A., & Chiara, M. (2017) · Oncotarget · doi:10.18632/oncotarget.14629 · Cited by 37
Xiao, H., & Shi, J. (2020) · Molecular Medicine Reports · doi:10.3892/mmr.2020.11541 · Cited by 36
“mir-210 is involved in numerous biological processes during the development of cancer, such as apoptosis, angiogenesis and dna damage response, and it is considered as potential biomarker and therapeutic target in numerous types of tumors, including rcc (26-30).”
BackgroundPamenter, M. E., Onganer, P. U., Huynh, K. W., Kraev, I., & Lange, S. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20215378 · Cited by 34
“and was found to have pro-apoptotic functions under normoxic conditions, but anti-apoptotic effects under hypoxic conditions [84,85].”
BackgroundRen, X., Yan, J., Zhao, Q., Bao, X., Han, X., Chen, Z., Zhou, Y., Chen, L., Wang, B., Yang, L., et al. (2023) · Cell Discovery · doi:10.1038/s41421-023-00558-8 · Cited by 32
“S bio-synthesis in the enhanced mitochondrial functions in tumor cells; however, IscU2 suppression was found to be able to decrease the activity of mitochondrial complex I and force an adaption to hypoxia in breast cancer cells 22,35 .”
MicroRNAs: are they the missing link between hypoxia and pre-eclampsia?
Li, J. Y. Z., Yong, T. Y., Michael, M., & Gleadle, J. (2013) · Hypertension in Pregnancy · doi:10.3109/10641955.2013.832772 · Cited by 31
“In a cancer cell line, down-regulation of ISCU by miR-210 decreases Krebs cycle enzyme activity and mitochondrial function, provides a major mechanism for the increased free radical generation in hypoxia, increases cell survival under hypoxia, induces a switch to glycolysis in normoxia and hypoxia (Warburg and Pasteur…”
BackgroundSelf-citationNoncoding RNAs in the Vascular System Response to Oxidative Stress
Fuschi, P., Maimone, B., Gaetano, C., & Martelli, F. (2019) · Antioxidants and Redox Signaling · doi:10.1089/ars.2017.7229 · Cited by 32
“In particular, miR-210 directly inhibits the expression of ISCU1/2 (22, 43, 44, 61), necessary for the assembly of Fe-S clusters that are present in several ETC and TCA cycle components (170).”
microRNAs: Potential glioblastoma radiosensitizer by targeting radiation-related molecular pathways
Bahreyni-Toossi, M.-T., Dolat, E., Khanbabaei, H., Zafari, N., & Azimian, H. (2019) · Mutation research. Fundamental and molecular mechanisms of mutagenesis · doi:10.1016/j.mrfmmm.2019.111679 · Cited by 35
MicroRNA‐210 Decreases heme Levels by Targeting Ferrochelatase in Cardiomyocytes
Qiao, A., Khechaduri, A., Mutharasan, R. K., Wu, R., Nagpal, V., & Ardehali, H. (2013) · Journal of the American Heart Association · doi:10.1161/jaha.113.000121 · Cited by 31
Ambrose, L. J. A., Jamil, A. H. A., Gomes, R. S. M., Carter, E. E., Carr, C. A., Clarke, K., & Heather, L. C. (2014) · Journal of Cardiovascular Pharmacology and Therapeutics · doi:10.1177/1074248414524480 · Cited by 34
“These effects were also observed in cancer cell lines, with ISCU suppression decreasing complex I and aconitase activities.(31) In contrast, the activity of complex IV in the present study decreased with hypoxia, but not with DMOG treatment, demonstrating HIFindependent regulation of the terminal complex of the ETC.”
BackgroundHIF1α-dependent uncoupling of glycolysis suppresses tumor cell proliferation
Urrutia, A. A., Mesa‐Ciller, C., Guajardo-Grence, A., Alkan, H. F., Soro-Arnáiz, I., Vandekeere, A., Campos, A. M. F., Igelmann, S., Fernández-Arroyo, L., Rinaldi, G., et al. (2024) · Cell Reports · doi:10.1016/j.celrep.2024.114103 · Cited by 34
microRNAs Tune Oxidative Stress in Cancer Therapeutic Tolerance and Resistance
Zhang, W. C. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20236094 · Cited by 30
“miR-210 activates generation of ROSs [145] via suppressing iron–sulfur cluster assembly enzyme [146,147] and cytochrome c oxidase assembly protein [148] in the mitochondria electron transport chain and the TCA cycle.”
BackgroundMicroRNA, Diabetes Mellitus and Colorectal Cancer
Wang, H. (2020) · Biomedicines · doi:10.3390/biomedicines8120530 · Cited by 29
Effect of OSW-1 on microRNA expression profiles of hepatoma cells and functions of novel microRNAs
Ji-chun, J., Jin, X., Zhang, X., Piao, Y., & Liu, S. (2013) · Molecular Medicine Reports · doi:10.3892/mmr.2013.1428 · Cited by 28
Regulation of iron homeostasis by microRNAs
Castoldi, M., & Muckenthaler, M. U. (2012) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-012-1031-4 · Cited by 34
Mitochondrial-related microRNAs and their roles in cellular senescence
Luo, L., An, X., Xiao, Y., Sun, X., Li, S., Wang, Y., Sun, W., & Yu, D. (2024) · Frontiers in Physiology · doi:10.3389/fphys.2023.1279548 · Cited by 34
Ismaeel, A., Fletcher, E., Miserlis, D., Wechsler, M. E., Papoutsi, E., Haynatzki, G. R., SMITH, R. S., Bohannon, W. T., & Koutakis, P. (2022) · Translational research · doi:10.1016/j.trsl.2022.03.003 · Cited by 29
Hypoxamirs and Mitochondrial Metabolism
Cottrill, K. A., Chan, S. Y., & Loscalzo, J. (2014) · Antioxidants and Redox Signaling · doi:10.1089/ars.2013.5641 · Cited by 28
“These results are consistent across pulmonary arterial endothelial cells (14), tumorigenic cells of breast cancer (28), and trophoblasts in human placental tissue (56), reflecting the potential relevance of this finding to pathologies as disparate as pulmonary hypertension, preeclampsia, and cancer.”
BackgroundResultDeiminated proteins and extracellular vesicles - Novel serum biomarkers in whales and orca
Magnadóttir, B., Onganer, P. U., Kraev, I., Svansson, V., Hayes, P. M., & Lange, S. (2020) · Comparative Biochemistry and Physiology Part D Genomics and Proteomics · doi:10.1016/j.cbd.2020.100676 · Cited by 30
Friedreich Ataxia: New Pathways
Pandolfo, M. (2012) · Journal of Child Neurology · doi:10.1177/0883073812448534 · Cited by 29
The molecular rationale for therapeutic targeting of glutamine metabolism in pulmonary hypertension
Bertero, T., Perk, D., & Chan, S. Y. (2019) · Expert Opinion on Therapeutic Targets · doi:10.1080/14728222.2019.1615438 · Cited by 27
“However, via chronically repressing ISCU1/2 and Fe-S biogenesis, miR-210 acts as an intracellular pathogenic factor in pulmonary arterial cells to induce oxidative stress and to promote PH in vivo.”
BackgroundInsights into the Role of microRNAs in Colorectal Cancer (CRC) Metabolism
Hon, K. W., Abidin, S. A. Z., Othman, I., & Naidu, R. (2020) · Cancers · doi:10.3390/cancers12092462 · Cited by 34
“MiR-210 also upregulated the ROS generation in CRC cells in response to hypoxia [28,48].”
BackgroundAltered Gene Expression Associated with microRNA Binding Site Polymorphisms
Võsa, U., Esko, T., Kasela, S., & Annilo, T. (2015) · PLoS ONE · doi:10.1371/journal.pone.0141351 · Cited by 31
“ISCU codes a protein with a functional role in the assembly of mitochondrial iron-sulfur clusters.”
BackgroundInfluential
Metadata
- Authors
- Favaro, E., Ramachandran, A., McCormick, R., Gee, H., Blancher, C., Crosby, M., Devlin, C., Blick, C., Buffa, F., Li, J.-L., Vojnovic, B., Pires das Neves, R., Glazer, P., Iborra, F., Ivan, M., Ragoussis, J., & Harris, A. L.
- Affiliations
- Centre for Human Genetics (GB)
- John Radcliffe Hospital (GB)
- Yale University (US)
- Indiana University Indianapolis (US)
- University of Oxford (GB)
- Corresponding author
- Ivan, Mircea
- Harris, Adrian L.
- ORCID
- Venue
- PLoS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2010-04-26
- Volume
- 5
- Issue
- 4
- Pages
- e10345
- ISSN
- 1932-6203 (ISSN-L)
- PMC
- PMC2859946
- OpenAlex
- W2044291869
- Cited by
- 324
- References
- 46
- Citations by year
- 2026: 7 · 2025: 9 · 2024: 7 · 2023: 12 · 2022: 12 · 2021: 33 · 2020: 14 · 2019: 20 · 2018: 11 · 2017: 23 · 2016: 14 · 2015: 17 · 2014: 30 · 2013: 45 · 2012: 33
- FWCI
- 11.59
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Locations
- PLoS ONE (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Research Portal (King's College London) (publishedVersion, other-oa)
- PEARL (University of Plymouth) (submittedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Figshare (submittedVersion, cc-by)
- Archivio istituzionale della Ricerca - Bocconi (submittedVersion)
- IUScholarWorks (Indiana University) (submittedVersion, cc-by)
- Purdue University Indianapolis (Indiana University) (submittedVersion, cc-by)
- Publisher
- Funders
- Alliance for Cancer Gene Therapy
- Elsa U. Pardee Foundation
- Wellcome Trust
- Cancer Research UK
- National Institute for Health and Care Research
- University of Oxford
- European Commission
- Fondazione Italiana per la Ricerca sul Cancro
- Urology Foundation
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Hypoxia, and Metabolism
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › MicroRNA in disease regulation
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Ferroptosis and cancer prognosis
- Keywords
- miR-210, IscU, iron-sulfur cluster assembly, hypoxia, reactive oxygen species, TCA cycle, mitochondrial complex I, aconitase, HIF-1, tumor cell survival, prognosis, iron metabolism, microRNA target regulation
- MeSH terms
- Hypoxia, Citric Acid Cycle, Free Radicals, Humans, Iron-Sulfur Proteins, Mitochondria, Neoplasms, Prognosis, MicroRNAs, Electron Transport Complex I, Cell Line, Tumor, Hypoxia-Inducible Factor 1, alpha Subunit
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.